Valo

Valo Health's goal is to establish a new model for drug development. The company has collected a vast amount of multi-omics data from 8 million patients, using these human-derived data for target and drug discovery instead of relying on cell or other animal models. Meanwhile, its drug development platform applies artificial intelligence to the new drug discovery process, enabling the screening of hundreds of millions of molecules through computer simulations and rapid iteration. Currently, the company has two candidate drugs in clinical development and 15 research projects in the preclinical stage.